abstract |
The present invention relates to the compound of following general formula (I), and pharmacy acceptable salt, its tautomer, its steric isomer or with the mixture of the steric isomer of any ratio, as the mixture of enantiomer, especially racemic mixture, with and its production and use, especially as the purposes of antineoplastic agent. |